ondansetron + ketorolac + hydromorphone

A combination of **ondansetron**, **ketorolac**, and **hydromorphone** typically used in multimodal, patient-controlled analgesia (PCA) settings, especially for postoperative pain management. - **Hydromorphone** is a potent semi-synthetic opioid, acting primarily as a mu-opioid receptor agonist, providing strong analgesia for acute and chronic pain. - **Ketorolac** is a nonsteroidal anti-inflammatory drug (NSAID) that inhibits cyclooxygenase (COX) enzymes, reducing prostaglandin synthesis and thus pain and inflammation. It is used for its opioid-sparing effect, allowing reduced opioid dosage and associated side effects. - **Ondansetron** is a selective serotonin 5-HT3 receptor antagonist used to prevent or treat nausea and vomiting associated with analgesic therapy or surgery. By combining these agents, this formulation provides synergistic pain relief, minimizes opioid requirements and associated side effects, and controls nausea commonly observed postoperatively[1][2][4]. It is usually administered via intravenous PCA systems in clinical settings[2][3].

Other names

Pre-treatment analgesiaProcedural Analgesia for Liposonix Treatment